Agilent Feb 11, 2026 Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Business Wire
Agilent Feb 11, 2026 FDA approves first immunotherapy-linked test to guide ovarian cancer care - Stock Titan
Agilent Feb 11, 2026 Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com
Agilent Feb 11, 2026 Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc - MarketBeat
Illumina Feb 11, 2026 Ngs Oncology Market Is Going to Boom | Illumina • Roche • Thermo Fisher Scientific - openPR.com
Eppendorf Feb 11, 2026 Eppendorf collaborates with Dubai Police to automate forensics laboratories - News-Medical
Illumina Feb 11, 2026 Illumina Trying To Close In On Key Technical Benchmark - Investor's Business Daily
Illumina Feb 11, 2026 Illumina Trying To Close In On Key Technical Benchmark - Investor's Business Daily
FierceBiotech Feb 11, 2026 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
10x Genomics Blog Feb 11, 2026 10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
10x Genomics Blog Feb 11, 2026 10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - The Chronicle-Journal
BioPharma Dive Feb 11, 2026 Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug